ALX Oncology
ALXO
#9346
Rank
ยฃ0.10 B
Marketcap
ยฃ0.81
Share price
3.92%
Change (1 day)
-25.81%
Change (1 year)

Earnings for ALX Oncology (ALXO)

Earnings in 2026 (TTM): -ยฃ59.49 Million

According to ALX Oncology's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -ยฃ76.52 Million, an increase over its 2024 earnings that were of -ยฃ0.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ALX Oncology from 2019 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ59.49 Million-22.26%
2025 -ยฃ76.52 Million-24.81%
2024 -ยฃ0.11 Billion-16.4%
2023 -ยฃ0.13 Billion27.41%
2022 -ยฃ95.55 Million49.61%
2021 -ยฃ63.86 Million86.94%
2020 -ยฃ34.17 Million132.9%
2019 -ยฃ14.67 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-ยฃ0.12 Billion 96.44%๐Ÿ‡บ๐Ÿ‡ธ USA